Clorox (CLX) Misses Q4 EPS by 41c, Guidance Falls Short of Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Clorox (CLX) Falls Sharply as COVID-19 Demand Wanes
August 3, 2021 7:59 AM EDTShares of Clorox (NYSE: CLX) are down about 10% in pre-open Tuesday after the company saw fading demand for its products.
The companys biggest unit by revenue generated, the health and wellness division, witnessed a 17% decline in sales. The company recorded falling sales in three out of four business divisions as pandemic-shaped demand for Clorox waned.
Overall, sales... More
